Literature DB >> 25064460

Tigecycline for severe Clostridium difficile infection.

Ashley Thomas1, Farhan Khan1, Nizam Uddin2, Mark R Wallace3.   

Abstract

Limited data suggest that tigecycline may be of value in the treatment of Clostridiumdifficile infection. We reviewed our experience using tigecycline to treat severe c. difficile and compared outcomes to similarly ill patients who did not receive tigecycline. We found no difference between the groups. Further study is needed before tigecycline can be recommended for use in severe C. difficile infection.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Colitis; Tigecycline

Mesh:

Substances:

Year:  2014        PMID: 25064460     DOI: 10.1016/j.ijid.2014.04.025

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  10 in total

Review 1.  Management of adult Clostridium difficile digestive contaminations: a literature review.

Authors:  Fanny Mathias; Christophe Curti; Marc Montana; Charléric Bornet; Patrice Vanelle
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-29       Impact factor: 3.267

2.  Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.

Authors:  Casey M Theriot; Cassie A Schumacher; Christine M Bassis; Anna M Seekatz; Vincent B Young
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

3.  Impact of Tigecycline on C. difficile Outcomes: Case Series and Propensity-Matched Retrospective Study.

Authors:  Emma C Phillips; Cirle A Warren; Jennie Z Ma; Gregory R Madden
Journal:  Antimicrob Agents Chemother       Date:  2022-06-01       Impact factor: 5.938

4.  Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI.

Authors:  Bhagyashri D Navalkele; Stephen A Lerner
Journal:  Open Forum Infect Dis       Date:  2016-05-12       Impact factor: 3.835

Review 5.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

Review 6.  Clostridium difficile infection in the elderly: an update on management.

Authors:  Tomefa E Asempa; David P Nicolau
Journal:  Clin Interv Aging       Date:  2017-10-24       Impact factor: 4.458

7.  Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?

Authors:  Mary T LaSalvia; Westyn Branch-Elliman; Graham M Snyder; Monica V Mahoney; Carolyn D Alonso; Howard S Gold; Sharon B Wright
Journal:  Open Forum Infect Dis       Date:  2017-02-10       Impact factor: 3.835

Review 8.  Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection.

Authors:  Yuan-Pin Hung; Jen-Chieh Lee; Hsiao-Ju Lin; Hsiao-Chieh Liu; Yi-Hui Wu; Pei-Jane Tsai; Wen-Chien Ko
Journal:  Antibiotics (Basel)       Date:  2015-06-19

Review 9.  Leaping Forward in the Treatment of Clostridium Difficile Infection: Update in 2015.

Authors:  Joana Carmo; Susana Marques; Iolanda Chapim; Maria Ana Túlio; José Pedro Rodrigues; Miguel Bispo; Cristina Chagas
Journal:  GE Port J Gastroenterol       Date:  2015-08-31

Review 10.  Novel Antimicrobials for the Treatment of Clostridium difficile Infection.

Authors:  Nicola Petrosillo; Guido Granata; Maria Adriana Cataldo
Journal:  Front Med (Lausanne)       Date:  2018-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.